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Objective: Basic calciumphosphate (BCP) crystals, includingoctacalciumphosphate (OCP), carbonated-apatite
(CA) and hydroxyapatite (HA) crystals are associated with destructive forms of osteoarthritis. Mechanisms of
BCP-induced cartilage breakdown remain incompletely understood. We assessed the ability of BCP to induce
changes in intracellular calcium (iCa2þ) content and oscillations and the role of iCa2þ in BCP-induced cartilage
degradation.
Methods: Bovine articular chondrocytes (BACs) and bovine cartilage explants (BCEs) were stimulated
with BCP or monosodium urate (MSU) crystals. iCa2þ levels were determined by spectroﬂuorimetry and
oscillations by confocal microscopy. mRNA expression of matrix metalloproteinase 3 (MMP-3), a dis-
integrin and metalloprotease with thrombospondin-like motifs 4 (ADAMTS-4) and ADAMTS-5 was
assessed by quantitative real-time PCR. Glycosaminoglycan (GAG) release was measured in the super-
natants of BCE cultures.
Results: All three BCP crystals signiﬁcantly increased iCa2þ content. OCP also induced iCa2þ oscillations.
Rate of BACs displaying iCa2þ oscillations increased over time, with a peak after 20 min of stimulation.
OCP-induced iCa2þ oscillations involved both extracellular Ca2þ (eCa2þ) inﬂux and iCa2þ stores. Indeed,
OCP-induced iCa2þ oscillations decreased rapidly in Ca2þ-free medium. Both voltage- and non-voltage-
dependent Ca2þ channels were involved in eCa2þ inﬂux. BCP crystal-induced variation in iCa2þ
content was associated with BCP crystal-induced cartilage matrix degradation. However, iCa2þ was not
associated with OCP crystal-induced mRNA expression of MMP-3, ADAMTS-4 or ADAMTS-5.
Conclusion: BCP crystals can induce variation in iCa2þ content and oscillations in articular chondrocytes.
Furthermore, BCP crystal-induced changes in iCa2þ content play a pivotal role in BCP catabolic effects on
articular cartilage.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Basic calcium phosphate (BCP) crystals, a heterogeneous group
of apatite crystals including carbonated-apatite (CA), octacalcium
phosphate (OCP), hydroxyapatite (HA), immature amorphous Ca2þ
apatite, tricalcium phosphate1 and magnesium-substituted apatite
(whitlockite) crystals2,3, are associated with severe forms of oste-
oarthritis (OA) and destructive arthropathies. They are detected in
60% of OA synovial ﬂuid, of OA meniscus and in all knee and hip OA
cartilage harvested at the time of arthroplasty4e6. ArticularH.-K. Ea, Service de Rhuma-
2, Rue Ambroise Paré, 75010
-86-31.
s Research Society International. Pcartilage mineralization is a widespread phenomenon observed in
end-stage OA and involves the whole joint, including less weight-
bearing cartilage areas6,7. BCP crystal deposition in knee articular
cartilage is associated with cartilage destruction, more severe
clinical symptoms, and chondrocyte phenotype changes towards
hypertrophy as suggested by increased expression of type X
collagen and greater ability to produce BCPs in vitro4. BCP crystal
presence in synovial ﬂuid also predicts OA progression seen on
radiography8.
In vitro, as we recently reviewed, BCP crystals represent
a microcrystalline stress for both articular chondrocytes and
synovial ﬁbroblasts9. BCP crystals may stimulate articular cells
through two mechanisms. They can ﬁrst activate cells as endocy-
tosed or phagocytosed particles leading to intralysosomal crystal
dissolution with subsequent elevation of intracellular Ca2þ levelsublished by Elsevier Ltd. All rights reserved.
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activation by Ca2þ crystals involves a direct crystalecell membrane
interaction9. As a consequence of articular chondrocyte and syno-
vial ﬁbroblast activation by BCP crystals, several cell functions are
modulated. In ﬁbroblasts, BCP crystals induce cell proliferation,
proto-oncogene stimulation and production of inﬂammatory
cytokines [interleukin 1 (IL-1b), tumour necrosis factor a (TNF-a)],
matrix metalloproteases (MMP), collagenase, cyclo-oxygenase
(COX)-1 and -2 and prostaglandin E2 (PGE2)9. In articular chon-
drocytes, BCP crystals induce increased DNA synthesis and cell
division10, IL-1b mRNA overexpression11, nitric oxide and MMP-13
production10e12, increased caspase-3 activity and chondrocyte
apoptosis13. Altogether, these signiﬁcant articular chondrocyte
phenotype changes can be summarized into four major pheno-
types9: mitogenic10, pro-inﬂammatory11, catabolic10e12, and
apoptotic13 phenotypes, respectively.
BCP crystals activate several intracellular signalling pathways
depending on cell function and cell type, including pathways
dependent on Ras/Raf/mitogen-activated protein kinase (MAPK)
p42/p44, NF-kB, MAPK p38 and JNK MAPK and Ca2þ14. BCP crystals
induce variation in intracellular Ca2þ (iCa2þ) content in human
foreskin ﬁbroblasts (HFFs) by extracellular Ca2þ (eCa2þ) inﬂux and
intralysosomal dissolution of endocytosed crystals14,15. The iCa2þ
level is tightly balanced between the external source and internal
stores that are mainly located in the endoplasmic/sarcoplasmic
reticulum (ER). iCa2þ is a multifunctional secondarymessenger that
modulates several cellular functions like cell proliferation, differ-
entiation, migration, contraction and apoptosis and production of
inﬂammatory cytokines and MMPs. We recently found BCP crystal-
induced chondrocyte apoptosis partially dependent on iCa2þ level
secondary to BCP-crystal endocytosis and dissolution13. Similarly,
iCa2þ is involved in the production of MMPs and aggrecanases by
bovine articular cartilage explants stimulated by mechanical
compression16. Both MMPs and aggrecanases play a major role in
OA cartilage extracellular matrix destruction. Finally, BCP-crystal
endocytosis and dissolution with subsequent iCa2þ level increase
were involved in BCP crystal-induced HFF proliferation and
production of MMP-1 and MMP-13, PGE2 and TNF-a14. Therefore,
iCa2þ may have a major role in BCP crystal-induced cartilage
destruction in OA.
In this study, we investigated the mechanisms by which BCP
crystals increase iCa2þ level in articular chondrocytes. We also
assessed the role of iCa2þ in BCP crystal-induced proteoglycan
release.
Methods
BCP and monosodium urate (MSU) crystals
Sterile, pyrogen-free BCP and MSU crystals were synthesised
and characterized as described17. Crystals were suspended in
serum-free Dulbecco modiﬁed Eagle’s medium (DMEM; Invi-
trogen) and dispersed by brief sonication before use. For the indi-
cated times, BCP crystals did not induce eCa2þ level increase in the
culture medium (data not shown).
Isolation and culture of bovine articular chondrocytes (BACs)
Primary BACs were isolated from 3-year-old cow meta-
tarsophalangeal joints provided by a local French slaughterhouse as
described11. Brieﬂy, joint cartilage was cut into small pieces, and
BACs were released by digestion with type II bacterial collagenase
(SigmaeAldrich). BACs were plated at high density (107 cells/ml) in
high-glucose DMEM supplemented with 10% heat-inactivated
foetal bovine serum (PAA) and containing 100 g/ml streptomycin,100 IU/ml penicillin, and 0.25 mg/ml fungizone (hereafter referred
to as complete medium). Subconﬂuent cells were replated in
complete medium for 24 h at (1) 3 105 cells/well in 24-well plates
(for protein and mRNA analysis); (2) 6 104 cells/90 mL medium on
12  30 mm glass coverslips (for iCa2þ measurement with Fura-2);
(3) 5  105 cells/2 mL medium in 35-mm glass base dishes (Iwaki)
(for iCa2þ analysis by confocal microscopy with Fluo-4). Cells were
starved in serum-free DMEM overnight before the different tests. In
the aforementioned culture conditions, type II collagen expression
remained unchanged during the experiment times, up to
3 days11,13.
Isolation and culture of bovine articular cartilage explants
Cartilage slices (w30 mg dry weight each) were aseptically
dissected from 3-year-old cow metatarsophalangeal joint articular
cartilage and washed three times with serum-free and phenol-free
DMEM supplemented with antibiotics. Cartilage slices were
transferred to 24-well, ﬂat-bottomed plates (TPP; ATGC Bio-
technologie) containing 1 ml/well complete phenol-free medium
and cultured at 37C in a humidiﬁed atmosphere supplemented
with 5% CO2. Cartilages were starved overnight in phenol- and
serum-free medium and then stimulated with OCP crystals or
10 ng/ml recombinant human IL-1b (R&D Systems Inc.) in the
presence or not of BAPTA-AM (1 mM). After 48 h, supernatants were
collected. Glycosaminoglycan (GAG) release was measured by
a colourimetric assay with 1,9 dimethylenemethylene blue
(DMMB), with shark chondroitin 6-sulphate used as a standard, as
described18. GAG release was normalized to cartilage explant dry
weight. Cartilage explants were collected, parafﬁn embedded and
cut with 5 mm thick sections. Proteoglycan loss was assessed by
safranin-O staining.
Measurement of iCa2þ concentration with Fura-2
BACs seeded at 6  104 cells/rectangular glass coverslip were
cultured until conﬂuence in phenol-free DMEM, then incubated for
24 h in serum-free medium, and assayed for iCa2þ concentration as
described19e21. Cells were washed with Hanks’ HEPES, pH 7.4
(137 mMNaCl, 5.6 mMKCl, 0.441 mMKH2PO4, 0.442 mMNa2HPO4,
0.885 mM MgSO4$7H2O, 27.7 mM glucose, 1.25 mM CaCl2 and
25 mM HEPES), and loaded with 1 mM Fura-2/AM for 20 min in the
same buffer at room temperature. Then, BACs were washed three
times with Hanks’ HEPES and incubated with BCP or MSU crystals
for various times. The glass coverslip carrying the cells was then
inserted in a quartz cuvette containing 2.5 mL Hanks’ HEPES and
placed in a temperature-controlled (37C) Hitachi F-2500 spec-
troﬂuorometer (Sciencetec, Les Ulis, France). The Fura-2 ﬂuores-
cence response to iCa2þ concentrationwas calibrated from the 340/
380 nm ﬂuorescence ratio after subtraction of background ﬂuo-
rescence at 340 and 380 nm22. The dissociation constant for the
Fura-2/Ca2þ complex was 224 nM22. The values for Rmax and Rmin
were calculated from determinations with 25 mM digitonin (Sigma)
and 4 mM EGTA and enough Trisbase to increase the pH to >8.3
(Fig. 1).
Intracellular calcium measurement with Fluo-4 ﬂuoroprobe
BACs were cultured in glass-based dishes. Conﬂuent cells were
starved overnight, washed three times with Hanks’ HEPES and
incubated with 3 mM Fluo-4/AM (Invitrogen) and 0.06% pluronic
acid F-127 (Invitrogen), a non-ionic and non-denaturing detergent,
for 30 min, in the same buffer or in Ca2þ-free Dulbecco’s phosphate
buffered saline (Invitrogen) in the dark at room temperature. BACs
were then washed three times, and iCa2þ content was analysed by
Fig. 1. Changes in iCa2þ level measured by the Fura-2 method. BACs were treated HA, CA, OCP or MSU crystals or untreated as a control. The values for Rmax and Rmin were
calculated by use of 25 mM digitonin, 4 mM EGTA and 60 mM Trisbase to increase the pH >8.3.
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inversed microscope, MIMA2 platform INRA-CRJ). Fluo-4 was
excited by a blue argon laser with excitation wavelength 488 nm
and ﬂuorescence emission recorded at 515 nm iCa2þ concentration,
assessed by the intensity of the ﬂuorescence with ImageJ 1.35R
software, was continually recorded in real time during 30e60 min
after stimulation. For each experiment, we ensured that laser beam
stimulation alone (during 30 min) or ﬂuid ﬂow stimulation did not
induce iCa2þ. All experiments were performed in a heated chamber
at 37C.Change in iCa2þ level by pharmacological inhibitors
To reveal the mechanisms underlying BCP crystal-induced iCa2þ
content, we stimulated BAC and cartilage explants with BCP crys-
tals in the presence or not of following inhibitors to block speciﬁc
pathways of Ca2þ mobilization: verapamil (1 mM), nickel (5 nM),
benzamil (10 mM), and gadolinium (10 mM), U73122 (phospholipase
C inhibitor at 1 mM), thapsigargin (5 mM)19e21.
Cartilage explant cultures and BACs used for confocal micros-
copy were incubated with the inhibitor for 30 min before adding
BCP crystals, and Fura-2-loaded cells were incubated with the
inhibitor for 1 min before adding BCP crystals. For Ca2þ measure-
ment with the ﬂuoroprobe Fluo-4, BACs were treated when rate of
BAC displaying iCa2þ oscillations peaked 10e20 min after the
beginning of the stimulation.RNA isolation and quantitative real-time PCR
After 6-h stimulation, total RNA was extracted from BACs with
use of Trizol. RNA purity was assessed by measuring theabsorbance ratio at 260 nm/280 nm (Nanodrop ND1000, Thermo).
All measured samples were comprised between 1.9 and 2. RNAwas
reverse transcribed into cDNA with a High Capacity cDNA Reverse
Transcription kit (Applied Biosystems). After reverse transcription,
the cDNA product was ampliﬁed by real-time PCR. ThemRNA levels
for MMP-3, a disintegrin and metalloprotease with
thrombospondin-like motifs 4 (ADAMTS-4), ADAMTS-5 and
GAPDH as an internal control were determined by use of the double
strand-speciﬁc Power SYBR Green dye system (Applied Bio-
systems). PCR reactions were at 50C for 2 min, 95C for 10 min, 40
cycles at 95C for 15 s, then 60C for 1 min (data collection was
performed at the end of each annealing/extension step) (Light-
Cycler480, Roche). The third step was a dissociation process to
ensure the speciﬁcity of the amplicons by measuring their melting
temperature (Tm). Primer sequences for MMP-3, ADAMTS-4,
ADAMTS-5 and GAPDH were determined by the Universal Probe-
Library Assay Design Center (Roche Applied Science). Primer efﬁ-
ciency was measured. Data analysis involved use of SDS software
(Applied Biosystems). Analysis involved the 2DDCt method. Primer
sequences were for MMP-3, sense, 50-TGGACAAAGGATA-
CATCAGGAA-30 and antisense 50-TCACGTTCGGTTGAGTGCT-30;
ADAMTS-4, sense 50-GTGTGGTGGGGATGGTTC-30 and antisense 50-
CGTTGTTGTATCCGTACCTGAA-30; ADAMTS-5, sense 50-TCACGAG
GAGCACTATGACG-30 and antisense 50-AGCATATGGTCCCAACGTCT-
3; GAPDH, sense 50-AATTCTGGCAAAGTGGACATC-30 and antisense
50-GACCATGTAGTGAAGGTCAATGAA-30.Statistical analysis
Results are expressed as mean and 95% conﬁdence interval of at
least three independent experiments performed in quadruplicate,
Table II
OCP crystal-induced iCa2þ oscillations in isolated BACs
Time course % Oscillating BAC 95% CI P-value
30 min 0.153 0.156e0.462 e
0 min 4.411 2.381e6.441 <0.001y
5 min 8.750 4.657e12.843 0.049*
10 min 14.635 8.956e20.314 0.002*
15 min 16.311 7.924e24.698 <0.001*
20 min 21.075 6.803e35.347 <0.001*
30 min 12.517 6.744e18.289 0.006*
60 min 11.100 e 0.216*
Rate of BACs showing iCa2þ oscillations. Results are mean % BACs exhibiting iCa2þ
oscillations.
* P-value vs % at the beginning of the stimulation.
y P-value vs % before stimulation.
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5.0 (SAS Inst., Cary, NC). Non-parametric statistical tests were used
because normal distribution could not be demonstrated for all
variables. Comparisons between groups involved the Manne
Whitney U test. P < 0.05 was considered statistically signiﬁcant.
Results
BCP crystals dose- and time-dependently increased iCa2þ content in
BACs
The ability of BCP crystals to induce changes in iCa2þ content
was assessed by spectroﬂuorimetry in Fura-2-loaded cells. Five-
minute incubation with the three BCP crystals, OCP, HA and CA,
signiﬁcantly increased iCa2þ content, as compared with the unsti-
mulated control BAC (Table I). An equivalent dose of MSU crystals
had no effect. OCP and CA crystals were the most potent in
increasing iCa2þ content which is consistent with previous work17.
OCP-induced increase in iCa2þ level was dose and time dependent
(Table I). We thus focused on OCP crystals to study the mechanisms
of BCP crystal-induced variation in iCa2þ.OCP crystals induce iCa2þ oscillation
OCP crystal-induced iCa2þ variations were analysed in real time
by confocal microscopy with the ﬂuoroprobe Fluo-4. OCP crystals
induced iCa2þ transient increase, referred as iCa2þ oscillations31,
within seconds. The rate of BACs displaying iCa2þ oscillations
increased over time to peak between 15 and 20 min after OCP
stimulation (Table II). OCP crystals induced iCa2þ oscillations within
seconds in 4.4% of BACs, whereas no iCa2þ oscillation was observed
in BACs stimulated only by the microscope laser beam during at
least 30 min or by a ﬂuid ﬂow (Table II). The variations in iCa2þ
oscillations showed different patterns in terms of frequency of
iCa2þ ﬂuctuations and of ﬂuorescence levels: numerous BACs did
not show variation in iCa2þ oscillations, whereas some others
oscillated once, twice or more [Fig. 2(A)]. Oscillating cells were
randomly localised in the observation ﬁeld, and the oscillation
patterns did not suggest an iCa2þwave as described in gap-junctionTable I
BCP crystal-induced increase in intracellular calcium (iCa2þ) level in isolated BACs
Conditions iCa2þ fold-changes 95% CI P-value
iCa2D response in BACs after 5-min stimulation with 0.1 mg/mL BCP or MSU
crystals
Control 1.000 0.902e1.098 e
0.1 mg/ml OCP 2.302 1.789e2.815 <0.001*
0.1 mg/ml HA 1.348 1.128e1.568 0.005*, 0.006y
0.1 mg/ml CA 2.375 1.161e3.589 0.003*, 0.286y
0.1 mg/ml MSU 1.441 0.878e2.003 0.150*, 0.073y
Early kinetics of change in iCa2D level in BACs after stimulation with 0.1 mg/
mL OCP crystals
Control 1.000 0.902e1.098 e
0.1 mg/ml OCP at 1 min 1.321 0.691e1.951 0.160*
0.1 mg/ml OCP at 5 min 2.302 1.789e2.815 <0.001*
Doseeresponse of iCa2D level in BACs assessed after 5-min stimulation with
two doses of OCP crystals (0.05 mg/mL and 0.1 mg/mL)
Control 1.000 0.771e1.207 e
0.05 mg/ml OCP 1.484 1.029e1.949 0.122*
0.1 mg/ml OCP 2.422 1.674e3.154 0.007*
Changes in iCa2þ level measured by the Fura-2 method. BACs were treated HA, CA,
OCP or MSU crystals or untreated as a control. Data were obtained from at least
three independent experiments performed in duplicate. Results are mean fold
change in iCa2þ concentration compared to unstimulated control.
* P-value vs unstimulated control.
y P-value vs 0.1 mg/ml OCP at 5 min.propagation. Furthermore, the lack of iCa2þ oscillations in some
cells was not explained by a lack of interaction between crystals and
cells because an interaction was observed in all cells [Fig. 2(B)].
Compared to OCP crystals, HA and CA crystals were less effective in
inducing iCa2þ oscillations, and MSU crystals were ineffective (data
not shown).
eCa2þ inﬂux is involved in OCP-induced increase in iCa2þ oscillation
Incubating Fura-2-loaded cells for 1 min with 5 nM nickel (Niþ),
an inhibitor of non-voltage-dependent Ca2þ channel, or with 1 mM
verapamil (Ve), an L-type voltage-dependent Ca2þ channel inhib-
itor, before OCP stimulation signiﬁcantly decreased the iCa2þ
concentration (Table III). Conversely, iCa2þ levels remained
unchanged with 10 mM benzamil (Be), a Na Ca exchanger (NCX)
inhibitor. Gadolinium (Gd3þ) (10 mM), a stretch-activated Ca2þ
channel inhibitor, did not signiﬁcantly inﬂuence iCa2þ level
increase induced by OCP crystals (Table III). The same results were
observed with 1 mM U73122 (U73), a phospholipase C inhibitor
(Table III).
Ca2þ inﬂux and Ca2þ storage in ER are involved in OCP-induced
oscillations
Next, speciﬁc pathways of OCP-induced Ca2þ oscillations were
determined by using speciﬁc inhibitors. To examine the role of
eCa2þ, we performed OCP crystal stimulations in Ca2þ-free
medium. First, we ensured that OCP crystals did not dissolve during
the observation times. Indeed, Ca2þ was undetectable in the
supernatant of a solution with OCP crystals incubated for 3 h (data
not shown). Even in Ca2þ-free medium, OCP crystals induced iCa2þ
oscillations within seconds (Table IV). However, OCP-induced iCa2þ
oscillations decreased rapidly over time and were greatly inhibited
15 min after stimulation. In contrast, in medium containing
1.25 mM Ca2þ, OCP-induced iCa2þ oscillations lasted more than
60 min (Table IV). Therefore, OCP-induced iCa2þ oscillations
depended on iCa2þ stores and eCa2þ. This ﬁnding was conﬁrmed by
use of the pharmacological inhibitors Niþ and thapsigargin. Treat-
ment with 5 nM Niþ or 5 mM thapsigargin, a SERCA inhibitor,
between 10 and 20 min after BAC stimulation with OCP crystals
decreased within seconds the number of BACs exhibiting iCa2þ
oscillations (Table IV).
OCP-induced proteoglycan degradation is associated with variation
in iCa2þ content but not ADAMTS-4, ADAMTS-5 and MMP-3 mRNA
regulation
Because variations in iCa2þ have been found involved in carti-
lage degradation, we wondered whether OCP-induced iCa2þ
Fig. 2. OCP crystal-induced iCa2D oscillations in isolated BACs. (A) Number of oscillations for single BACs after stimulation with 0.1 mg/mL OCP crystals. Different types of
oscillations were observed. Representative results for eight different BACs from the observation ﬁeld are shown in Refs. 1 and2 (B) Projection in Z plane of an observation ﬁeld
showing all cells in contact with at least one microcrystal (white).
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glycan degradationwas abolished when articular cartilage explants
were pretreated with BAPTA-AM, an iCa2þ chelator, as assessed by
GAG release and safranin-O staining on parafﬁn embedded sections
(Table V and Fig. 3). OCP crystals also increased the mRNA
expression of MMP-3, ADAMTS-4, and ADAMTS-5. However, this
induction was not inhibited by 1 mM BAPTA-AM (Table VI). Thus,
iCa2þ was involved in OCP-induced proteoglycan degradation but
not OCP-induced mRNA expression of MMP-3, ADAMTS-4 or
ADAMTS-5.
Discussion
BCP crystals play a role in the pathogenesis of OA and are
responsible for microcrystalline stress4,5,9. BCP crystals directly
activate articular chondrocytes to produce prodegradative soluble
factors such as IL-1b, MMP-13, collagenase and nitric oxide9.However, the signalling pathways in the BCP crystal-induced direct
cellular effects on articular chondrocytes remain incompletely
understood. In the present study, we showed that BCP crystals
could induce early iCa2þ increase in content and oscillations in
BACs. BCP crystal-induced variation in iCa2þ content depended on
both eCa2þ sources and iCa2þ stores. Furthermore, iCa2þ was
involved in BCP crystal-induced proteoglycan degradation.
Microcrystal structures such as MSU and pyrophosphate Ca2þ
dihydrate calcium pyrophosphate dihydrated (CPPD) crystals
induced iCa2þ variation in polymorphonuclear neutrophils (PMNs)
through different mechanisms. Although they both increased iCa2þ
level in PMNs through the PLC/PI3K pathway, their effects were
modulated by protein coating23e28. This ﬁnding might explain the
discrepancy between our observations of MSU crystals unable to
increase iCa2þ level or iCa2þ oscillations at a 10-fold less concen-
tration (0.1 mg/ml). The cell species might also have inﬂuenced the
differential iCa2þ cell response to microcrystal stimulation, because
Table III
Mechanisms of OCP crystal-induced iCa2þ changes were assessed with iCa2þ
modulators
Conditions iCa2þ fold-changes 95% CI P-value*
L-type Ca2D voltage-dependent channels
Control
0.458
0.360e0.557 0.002
0.1 mg/ml OCP
1.000
0.905e1.095 e
0.1 mg/ml
OCP þ 1 mM
verapamil
0.619
0.418e0.820 0.008
Non-voltage-dependent Ca2D channels
Control
0.361
0.298e0.425 0.026
0.1 mg/ml OCP
1.000
0.200e1.800 e
0.1 mg/ml
OCP þ 5 nM
nickel
0.461
0.297e0.62 0.011
NaD/Ca2D exchanger
Control 0.509 0.332e0.685 0.050
0.1 mg/ml OCP 1.000 0.780e1.220 e
0.1 mg/ml OCP þ 10 mM
benzamil
0.918 0.893e0.943 0.564
Ca2D stretch-activated channels
Control 0.807 0.767e0.847 0.083
0.1 mg/ml OCP 1.000 0.759e1.241 e
0.1 mg/ml OCP þ 10 mM
gadolinium
0.846 0.381e1.311 0.221
Phospholipase C (PLC)-dependent Ca2D release
Control 0.404 0.327e0.480 <0.001
0.1 mg/ml OCP 1.000 0.736e1.264 e
0.1 mg/ml OCP þ 1 mM
U73122
0.838 0.697e0.979 0.569
Used pharmacological inhibitors acted either on Ca2þ inﬂux at the cell membrane
(1 mM verapamil, 5 nM nickel, 10 mM benzamil, and 10 mM gadolinium) or on Ca2þ
release from the ER (1 mMU73122). BACs were incubated for 20minwith 1 mMFura-
2 photoactive dye, then for 1 min with iCa2þ modulator, then 5 min with OCP
crystals (0.1 mg/mL). Then iCa2þ concentration was determined. Data were obtained
from at least three independent experiments performed in duplicate. Results are
mean fold-changes in iCa2þ concentration compared to OCP-stimulated BAC.
* P-value calculated vs 0.1 mg/ml OCP.
Table IV
Mechanisms of OCP crystal-induced iCa2þ oscillations in isolated BACs: role of
calcium inﬂux (eCa2þ) and iCa2þ stores
Time
course
% Oscillating
BAC
95% IC % Oscillating
BAC
95% IC P-
value*
0.1 mg/ml OCP 0.1 mg/ml OCPD Ca2D-free
medium
30 min 0.325 0.312e0.013 0.333 0.320e0.013 0.540
0 min 3.087 1.229e4.316 9.333 8.309e1.358 0.676
5 min 9.560 4.070e13.630 6.133 1.831e7.965 0.549
10 min 17.733 1.805e19.538 3.267 0.093e3.174 0.050
15 min 6.100 4.336e10.436 0.667 0.640e0.027 0.076
20 min 6.900 6.428e13.628 1.000 0.200e1.200 0.050
30 min 13.167 9.259e22.426 0.667 0.640e0.027 0.046
0.1 mg/ml OCP 0.1 mg/ml OCPD 5 nM
nickel at 10 min
10 min 0.167 0.160e0.493 e e e
0 min 8.650 3.311e13.989 e e e
5 min 14.900 9.409e20.391 e e e
10 min 27.580 18.172e36.988 20.000 18.222e21.778 0.177
20 min 51.033 21.503e80.563 10.367 8.055e12.678 0.046
25 min 17.1 16.708e17.492 2.9 2.381e3.419 0.083
0.1 mg/ml OCP 0.1 mg/ml OCPD 5 mM
thapsigargin at 15 min
10 min 0.217 0.208e0.641 e e e
0 min 4.307 1.748e4.289 e e e
5 min 9.473 2.629e9.371 e e e
10 min 11.733 3.611e18.161 e e e
15 min 10.533 1.785e19.282 2.600 2.496e7.696 0.014
20 min 25.200 16.744e33.659 0.667 0.640e1.973 0.032
30 min 5.600 4.320e6.880 1.000 0.960e2.960 0.076
Mechanisms involved in OCP-induced iCa2þ oscillations were assessed by confocal
microscopy with iCa2þ modulators that acted on Ca2þ inﬂux at the cell membrane
(Ca2þ-free medium, 5 nM nickel) or Ca2þ storage in the ER (5 mM thapsigargin). BACs
were treated as in Table III, then with iCa2þ modulators when the rate of BAC with
iCa2þ oscillations peaked between 10 and 20 min after the beginning of the stim-
ulation. Free cytosolic Ca2þ oscillation was determined. Data were obtained from at
least three independent experiments. Results are mean ratio of BACs exhibiting
iCa2þ oscillations.
* P-value calculated between iCa2þ modulators vs 0.1 mg/ml OCP.
Table V
iCa2þ-dependent mechanism of OCP crystal-induced GAG release in BCE
supernatants
Conditions GAG
fold-changes
95% CI P-value
Control 1.013 0.988e1.037 e
0.1 mg/ml OCP 1.877 1.365e2.390 <0.001*
0.1 mg/ml OCP þ 0.1 mM BAPTA-AM 1.163 0.841e1.486 0.038y
0.1 mg/ml OCP þ 1 mM BAPTA-AM 0.930 0.695e1.165 0.005y
10 ng/ml IL-1b 2.468 0.077e5.014 0.002*
1 mM ionomycin 1.497 0.905e2.089 0.299*
1 mM BAPTA-AM 0.904 0.761e1.047 0.299*
Cultured BCEs similar in size and weight (w30 mg dry weight each) were treated
with or without doses of BAPTA-AM, 1 mM ionomycin, 10 ng/mL rhIL-1b or 1 mM
BAPTA-AM alone. Control BCEs were left untreated for 48 h. GAG content was
determined by DMMB assay. Data were obtained from at least ﬁve independent
experiments performed in quadruplicate. GAG release was standardized to BCE dry
weight. Results are mean fold change in GAG as compared to unstimulated control.
* P-value calculated vs control.
y P-value calculated vs 0.1 mg/mL OCP crystals.
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depending on the cell species and cell functions14. For example, MSU
crystals increased iCa2þ level within 60e80 s mainly through ER
iCa2þ storage release by PLC/PI3K activation in PMNs23e28.
Conversely, in HFFs, MSU crystals increased iCa2þ level solely
through eCa2þ inﬂux15. However, in this latter study, basal iCa2þ
levels in HFFs (268  35 nM), as well as MSU-induced iCa2þ level
(around 1500 nM), was strikingly high.
The ability of BCP crystals to induce iCa2þ variations was
previously observed in HFFs15. BCP crystals yielded two peaks of
iCa2þ increase: a very early and immediate phase and a second, late
increase in iCa2þ level that started at 60 min and continued to
increase up to at least 3 h15. The very early-phase iCa2þ increase
reached 2000 nMwithin 1min after BCP stimulation, with a peak of
3000e4000 nM,which returned to basal level after 8min. The early
phase was reduced with use of Ca2þ-free medium, which suggests
that the effect was mainly due to massive eCa2þ inﬂux. However,
a small transient increase in iCa2þ level was observed even in
Ca2þ-free medium, which suggests a release of Ca2þ from
intracellular stores. The second phase of iCa2þ increase was
considered to be secondary to intracellular dissolution of
phagocytosed crystals15. In our study, OCP, CA and HA crystals
also induced an early increase in iCa2þ level (reaching 275 nM vs
82.5 nM, on average, in untreated BACs) within 1 min. The
magnitude of the effect of the three BCP crystal types differed,which is consistent with previously reported pro-inﬂammatory
properties of BCP crystals associated with crystal-speciﬁc surface
and ratio of Ca2þ to P17. We did not assess the second phase of iCa2þ
described by Halverson et al.17 However, we investigated the
mechanisms by which BCP crystals modulated iCa2þ level.
Using pharmacological inhibitors, we found that BCP crystal-
induced increase in iCa2þ content depended mainly on eCa2þ.
Fig. 3. iCa2D-dependent mechanism of OCP crystal-induced proteoglycan loss. Cultured BCEs similar in size and weight (w30 mg dry weight each) were treated with or without
doses of BAPTA-AM, 0.1 mg/ml OCP, 10 ng/mL rhIL-1b or 1 mM BAPTA-AM alone. Control BCEs were left untreated for 48 h. Proteoglycan loss was assessed by safranin-O staining on
parafﬁn embedded explant sections (representative histologic images of three independent experiments performed in quadruplicate).
C. Nguyen et al. / Osteoarthritis and Cartilage 20 (2012) 1399e1408 1405OCP crystal-induced eCa2þ inﬂux occurred through voltage- and
non-voltage-dependent Ca2þ channels in Fura-2-loaded BACs.
Our results also suggested that BCP crystal-induced iCa2þ vari-
ations involved Ca2þ mobilisation from intracellular stores because
early iCa2þ oscillations weremaintained even in Ca2þ-freemedium.
Furthermore, ER stores participated in OCP-induced iCa2þ oscilla-
tions, because thapsigargin completely inhibited OCP crystal-
induced oscillations. Although the effect of the PLC inhibitor
(U73122) linked to phosphatidyl-inositol 4,5 bisphosphate hydro-
lysis was difﬁcult to ascertain in Fura-2-loaded BACs, it slightly
reduced the OCP-induced increase in iCa2þ level at 5 min, which
suggests the involvement of the ER. BCP crystals may act in articular
chondrocytes via Ca2þ inﬂux and Ca2þ mobilisation from the ER.
The role of mitochondrial and ER stores through ryanodine recep-
tors should be further assessed.
Confocal microscopy showed that OCP crystals induced an
increase in iCa2þ level and stimulated iCa2þ oscillations, an effectTable VI
Inﬂuence of variation in iCa2þ level on OCP crystal-induced mRNA expression of MMP-3
Conditions ADAMTS-4 AD
mRNA
fold-changes
95% CI P-value mR
fold
Control 1.000 0.986e2.001 e 1.0
0.1 mg/ml OCP 8.162 4.446e12.608 0.001* 3.6
0.1 mg/ml OCP þ 1 mM BAPTA-AM 6.352 4.931e11.283 0.688y 3.2
10 ng/ml IL-1b 3.217 2.220e5.437 0.001* 2.8
BACs were pretreated with 1 mMBAPTA-AM, as indicated, then stimulated with 0.1 mg/m
analysis of mRNA levels of MMP-3, ADAMTS-4 and ADAMTS-5. Data were obtained from a
fold change in mRNA expression compared to unstimulated control.
* P-value vs control.
y P-value vs 0.1 mg/mL OCP crystals.well described in mechanical stress16,29 or in excitable cells such as
cardiomyocytes and neuron cells30,31. OCP-induced iCa2þ oscilla-
tions involved both eCa2þ and iCa2þ sources. They depended on
voltage- and non-voltage-dependent Ca2þ channels, as well as ER
stores, because thapsigargin inhibited OCP crystal-induced oscil-
lations. Of note, only a limited number of articular chondrocytes
showed transient iCa2þ elevation when in contact with OCP crys-
tals. This phenomenon might be explained by the presence of
heterogeneous subpopulations in isolated primary cultured BACs.
Some cell phenotype characteristics might prompt cells to display
iCa2þ changes.
BCP crystals can directly induce changes in iCa2þ in articular
chondrocytes, as was demonstrated for other types of stresses
including mechanical16,32e34, oxydative35 or cytokine-induced36,37
stresses, pH condition variations38, or hormonal stimuli21.
iCa2þ represents a main regulator of cellular activities, and
ﬂuctuations in iCa2þ are thought to be one mechanism by which, ADAMTS-4 and ADAMTS-5 in isolated BACs
AMTS-5 MMP-3
NA
-changes
95% CI P-value mRNA
fold-changes
95% CI P-value
00 0.986e1.042 e 1.000 0.986e1.042 e
54 1.969e4.604 <0.001* 4.053 2.870e5.237 <0.001*
86 2.341e4.232 0.668y 3.153 1.965e4.340 0.949y
86 1.586e4.187 <0.001* 1.936 1.673e2.231 <0.001*
L OCP crystals or 10 ng/mL recombinant human IL-1b (rhIL-1b) for 6 h. Real-time PCR
t least three independent experiments performed in quadruplicate. Results are mean
C. Nguyen et al. / Osteoarthritis and Cartilage 20 (2012) 1399e14081406articular chondrocytes transduce stress-induced signals into bio-
logical responses, especially catabolic events. Because BCP crystals
have been shown to induce such catabolic phenotype changes in
articular chondrocytes9, some of these changes could be mediated
by iCa2þ. Indeed, we found that OCP crystal-induced proteoglycan
loss and GAG release but not mRNA level of MMP-3, ADAMTS-4 and
ADAMTS-5 depended on increased iCa2þ level. This ﬁnding
suggests a post-transcriptional regulation of these three proteases
or the involvement of other proteases in proteoglycan degradation.
Consistent with our ﬁndings, several experimental data support
that iCa2þ variations can mediate catabolic responses in articular
chondrocytes and other cell types, even though full signalling
pathways remain under investigation. In osteoblasts stimulated by
compressive mechanical stress, increased iCa2þ level induced IL-6
and prostaglandin production39. Ex vivo, in a model of
mechanically-induced stress of equine cartilage explants, alter-
ations in Ca2þ homeostasis led to increased proteoglycan release40.
In vivo, in the adjuvant-induced arthritis rat model, treatment with
amiloride, a voltage-gated Ca2þ channel blocker, signiﬁcantly
decreased Mankin scores, increased type II collagen and aggrecan
mRNA and protein expression and reduced articular cartilage
destruction. In the anterior cruciate ligament section OA dogmodel,
oral treatment with PD-0200347, an alpha(2) delta ligand of
voltage-activated Ca2þ channels, signiﬁcantly reduced the
progression of cartilage structural changes by reducing MMP-13
and iNOS gene expression and inhibiting Erk1/2 activation via
a Ras-independent mechanism41,42. More recently, it has been
shown that cytosolic Ca2þ variations induced by transforming
growth factor b1 in articular chondrocytes were modulated by L-
and T-voltage-operated Ca2þ-channels. These iCa2þ variations led
to enhanced activation of Ank promoter through ERK1/2 and PKCa
pathways activation, and thus promote extracellular inorganic
pyrophosphate production43. These ﬁndings suggest that iCa2þ
changes induced by various stimulations may be involved in
promineralizing chondrocyte phenotype induction.
In summary, our results suggest that iCa2þ signalling could be
a major pathway involved in BCP crystal-induced direct cell acti-
vation and catabolic effects on articular chondrocytes. Our data
highlight a new pathophysiological mechanism and suggest
a potential therapeutic target in BCP deposition-associated diseases
including OA.
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